IBDEI0KN ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9779,0)
 ;;=373.34^^44^557^52
 ;;^UTILITY(U,$J,358.3,9779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9779,1,3,0)
 ;;=3^Eyelid,Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,9779,1,4,0)
 ;;=4^373.34
 ;;^UTILITY(U,$J,358.3,9779,2)
 ;;=^269064
 ;;^UTILITY(U,$J,358.3,9780,0)
 ;;=373.9^^44^557^37
 ;;^UTILITY(U,$J,358.3,9780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9780,1,3,0)
 ;;=3^Eyelid Inflammation,NOS
 ;;^UTILITY(U,$J,358.3,9780,1,4,0)
 ;;=4^373.9
 ;;^UTILITY(U,$J,358.3,9780,2)
 ;;=^269070
 ;;^UTILITY(U,$J,358.3,9781,0)
 ;;=374.21^^44^557^75
 ;;^UTILITY(U,$J,358.3,9781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9781,1,3,0)
 ;;=3^Lagophthalmos,Paralytic
 ;;^UTILITY(U,$J,358.3,9781,1,4,0)
 ;;=4^374.21
 ;;^UTILITY(U,$J,358.3,9781,2)
 ;;=^269091
 ;;^UTILITY(U,$J,358.3,9782,0)
 ;;=374.22^^44^557^74
 ;;^UTILITY(U,$J,358.3,9782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9782,1,3,0)
 ;;=3^Lagophthalmos,Mechanical
 ;;^UTILITY(U,$J,358.3,9782,1,4,0)
 ;;=4^374.22
 ;;^UTILITY(U,$J,358.3,9782,2)
 ;;=^269093
 ;;^UTILITY(U,$J,358.3,9783,0)
 ;;=374.23^^44^557^73
 ;;^UTILITY(U,$J,358.3,9783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9783,1,3,0)
 ;;=3^Lagophthalmos,Cicatricial
 ;;^UTILITY(U,$J,358.3,9783,1,4,0)
 ;;=4^374.23
 ;;^UTILITY(U,$J,358.3,9783,2)
 ;;=^269095
 ;;^UTILITY(U,$J,358.3,9784,0)
 ;;=374.31^^44^557^42
 ;;^UTILITY(U,$J,358.3,9784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9784,1,3,0)
 ;;=3^Eyelid Ptosis,Paralytic
 ;;^UTILITY(U,$J,358.3,9784,1,4,0)
 ;;=4^374.31
 ;;^UTILITY(U,$J,358.3,9784,2)
 ;;=^269097
 ;;^UTILITY(U,$J,358.3,9785,0)
 ;;=374.32^^44^557^41
 ;;^UTILITY(U,$J,358.3,9785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9785,1,3,0)
 ;;=3^Eyelid Ptosis,Myogenic
 ;;^UTILITY(U,$J,358.3,9785,1,4,0)
 ;;=4^374.32
 ;;^UTILITY(U,$J,358.3,9785,2)
 ;;=^269098
 ;;^UTILITY(U,$J,358.3,9786,0)
 ;;=374.33^^44^557^40
 ;;^UTILITY(U,$J,358.3,9786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9786,1,3,0)
 ;;=3^Eyelid Ptosis,Mechanical
 ;;^UTILITY(U,$J,358.3,9786,1,4,0)
 ;;=4^374.33
 ;;^UTILITY(U,$J,358.3,9786,2)
 ;;=^269099
 ;;^UTILITY(U,$J,358.3,9787,0)
 ;;=374.34^^44^557^26
 ;;^UTILITY(U,$J,358.3,9787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9787,1,3,0)
 ;;=3^Eyelid Blepharochalasis/Pseudoptosis
 ;;^UTILITY(U,$J,358.3,9787,1,4,0)
 ;;=4^374.34
 ;;^UTILITY(U,$J,358.3,9787,2)
 ;;=^15275
 ;;^UTILITY(U,$J,358.3,9788,0)
 ;;=374.41^^44^557^44
 ;;^UTILITY(U,$J,358.3,9788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9788,1,3,0)
 ;;=3^Eyelid Retraction/Lag
 ;;^UTILITY(U,$J,358.3,9788,1,4,0)
 ;;=4^374.41
 ;;^UTILITY(U,$J,358.3,9788,2)
 ;;=^269101
 ;;^UTILITY(U,$J,358.3,9789,0)
 ;;=374.43^^44^557^25
 ;;^UTILITY(U,$J,358.3,9789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9789,1,3,0)
 ;;=3^Eyelid Abn Innervation Synd
 ;;^UTILITY(U,$J,358.3,9789,1,4,0)
 ;;=4^374.43
 ;;^UTILITY(U,$J,358.3,9789,2)
 ;;=^269102
 ;;^UTILITY(U,$J,358.3,9790,0)
 ;;=374.46^^44^557^27
 ;;^UTILITY(U,$J,358.3,9790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9790,1,3,0)
 ;;=3^Eyelid Blepharophimosis
 ;;^UTILITY(U,$J,358.3,9790,1,4,0)
 ;;=4^374.46
 ;;^UTILITY(U,$J,358.3,9790,2)
 ;;=^15279
 ;;^UTILITY(U,$J,358.3,9791,0)
 ;;=374.50^^44^557^30
 ;;^UTILITY(U,$J,358.3,9791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9791,1,3,0)
 ;;=3^Eyelid Degen D/O,Unspec
 ;;^UTILITY(U,$J,358.3,9791,1,4,0)
 ;;=4^374.50
 ;;^UTILITY(U,$J,358.3,9791,2)
 ;;=^269106
 ;;^UTILITY(U,$J,358.3,9792,0)
 ;;=374.52^^44^557^34
 ;;^UTILITY(U,$J,358.3,9792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9792,1,3,0)
 ;;=3^Eyelid Hyperpigmentation
 ;;
 ;;$END ROU IBDEI0KN
